Investor Relations

LENSAR is the leading innovator in robotic laser cataract surgery

Our Mission

To Empower Cataract Surgeons to Deliver Superior Patient Outcomes through Robotic Laser Technology

June 2022
ALLY Receives U.S. FDA Clearance
Over 100
ALLY Systems Installed as of September 30, 2024
6.8 M+
procedures performed, worldwide
30 %
U.S. Procedure Market Share as of September 30, 2024

Annual Report

Events

More events are coming soon.